Before giving Methergine or Pitocin, in which condition is it documented that the medication should be avoided?

• A. Hypotension
• B. Peripheral vascular disease
• C. Hypothyroidism
• D. Type 1 diabetes

Answer: (B)

Peripheral vascular disease makes the use of uterotonic medications riskier because they can alter vascular tone and blood flow. Methergine (methylergonovine) is a potent vasoconstrictor used to increase uterine tone, and its systemic vasoconstrictive effect can further compromise blood flow to tissues in someone with vascular disease, raising the danger of ischemia. Because of this, methergine is contraindicated when peripheral vascular disease is present.

Pitocin (oxytocin) is another uterotonic given to stimulate contractions, and while its primary action is on uterine muscle, it can affect systemic hemodynamics as well, particularly with high-dose infusions. In the context of peripheral vascular disease, avoiding these agents helps prevent any additional stress on compromised vessels and potential perfusion problems.

Other conditions listed—hypotension, hypothyroidism, type 1 diabetes—do not have the same established contraindication to these medications. The key concept is that vascular disease raises the risk of adverse effects from drugs that influence vascular tone and perfusion, so peripheral vascular disease is the documented reason to avoid these uterotonic medications.